Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
Magnetic therapy brings breakthrough for depression, increasing treatment efficacy without cognitive cost
A new approach to treating severe depression using magnetic fields better preserves…
Understanding Cushing’s disease: causes, symptoms, and treatment options
Cushing's syndrome is a condition caused by long-term exposure to high concentrations…
Designer babies are now teenagers, and some may need treatment because of that
Achievement is highly valued in these families. I think this way of…
Deadly spider venom used as heart attack treatment
Our ailing hearts may someday thank the poisonous spider. Australian scientists are…
Gypsy Rose encourages Menendez Brothers to seek treatment after release from prison
Play video content back grid gypsy rose blanchard The Menendez brothers have…
Optimizing scorpion toxin treatment using artificial intelligence
Optimizing scorpion toxin treatment using artificial intelligenceabstractScorpion toxins are relatively short cyclic…
Stem cell transplant offers hope for treatment of age-related vision loss
A hole in the retina can cause your vision to become patchy…
StrataPT secures $25 million to advance outpatient treatment practice
Billing management software provider StrataPT has secured $25 million in funding in…
Immune response thought to help cancer may lead to unexpected treatment: ScienceAlert
Tap cancer A patient's "yin and yang" immunity may help increase their…
